I got my degree at Boston University in 2013. I then trained under Dr. Francisco Quintana at Brigham and Women’s Hospital for 3 and a half years where my work focused on understanding mechanisms of tolerogenic dendritic cell induction, regulation of innate immune cell activation in the central nervous system, and development of nanoparticle therapeutics.…Read more

David Alleva, Ph.D., has over 20 years of experience as a scientific leader in drug discovery and development of immunotherapeutics and vaccines in several biopharmaceutical companies and has published over 30 research articles in peer-reviewed journals. He developed one of the first antigen-specific immunotherapeutic clinical candidates for type 1 diabetes (T1D), an altered peptide ligand of insulin…Read more

Dr. Stephen Miller is the Judy E. Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine in Chicago.  He received his Ph.D. in 1975 from the Pennsylvania State University and did postdoctoral training at the University of Colorado Health Sciences Center before joining the faculty at Northwestern in 1981 where he currently serves as Director of the Northwestern University Interdepartmental Immunobiology Center.  Dr. Miller is internationally…Read more